Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Amortization of Deferred Charges (2016 - 2025)

Amicus Therapeutics filings provide 12 years of Amortization of Deferred Charges readings, the most recent being $676000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges rose 13.23% to $676000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 13.62% increase, with the full-year FY2025 number at $2.6 million, up 13.62% from a year prior.
  • Amortization of Deferred Charges hit $676000.0 in Q4 2025 for Amicus Therapeutics, up from $658000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $721000.0 in Q3 2023 to a low of $531000.0 in Q1 2024.
  • Median Amortization of Deferred Charges over the past 5 years was $641500.0 (2021), compared with a mean of $628600.0.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 140.26% in 2021 and later dropped 20.39% in 2024.
  • Amicus Therapeutics' Amortization of Deferred Charges stood at $638000.0 in 2021, then increased by 5.17% to $671000.0 in 2022, then dropped by 20.12% to $536000.0 in 2023, then rose by 11.38% to $597000.0 in 2024, then rose by 13.23% to $676000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $676000.0 (Q4 2025), $658000.0 (Q3 2025), and $630000.0 (Q2 2025) per Business Quant data.